GW27-e0882 Low-dose ticagrelor yields similar antiplatelet efficacy as standard-dose ticagrelor in healthy Chinese subjects: an open-label, randomized, controlled trial

Abstract

Ticagrelor has greater antiplatelet efficacy compared with clopidogrel, but may be accompanied by an increased risk of bleeding. This study evaluated the antiplatelet effect and pharmacokinetic profile of low-dose ticagrelor in healthy Chinese volunteers. Thirty healthy subjects were randomized to